Deutsche Biotech Innovativ AG Share Price
Equities
DBI
DE000A0Z25L1
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1.35 EUR | -10.60% | +35.00% | -82.80% |
Sales 2021 | - | Sales 2022 | - | Capitalization | 25.39M 27.22M 2.27B |
---|---|---|---|---|---|
Net income 2021 | - 0 0 | Net income 2022 | - 0 0 | EV / Sales 2021 | - |
Net cash position 2021 | 18.92K 20.29K 1.69M | Net cash position 2022 | 8.08K 8.66K 722K | EV / Sales 2022 | - |
P/E ratio 2021 |
-371
x | P/E ratio 2022 |
-107
x | Employees | 1 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99% |
1 day | -10.60% | ||
1 week | +35.00% | ||
Current month | +29.81% | ||
1 month | +29.81% | ||
3 months | -74.29% | ||
6 months | -79.55% | ||
Current year | -82.80% |
Managers | Title | Age | Since |
---|---|---|---|
Bernd Wegener
CEO | Chief Executive Officer | 76 | 01/09/01 |
Metod Miklus
COO | Chief Operating Officer | 65 | 07/19/07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernd Wegener
CEO | Chief Executive Officer | 76 | 01/09/01 |
Metod Miklus
COO | Chief Operating Officer | 65 | 07/19/07 |
Renke Lührs
CHM | Chairman | 64 | 15/11/15 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 1.35 | -10.60% | 6 |
25/24/25 | 1.51 | +37.27% | 30 |
End-of-day quote BOERSE DUESSELDORF, April 26, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-82.80% | 1.37M | |
+1.51% | 42.75B | |
+47.98% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- DBI Stock